NEW YORK, Dec 24 (Reuters) - Packaged food makers and fast-food restaurants may be forced to overhaul more of their products next year as newly approved, appetite-suppressing GLP-1 pills become available in January, analysts say. More Americans are expected to try the drugs as a pill rather than as a shot because the medication will be cheaper and many patients are hesitant to inject themselves.
Dec 24 () - Shares of Agios Pharmaceuticals jumped nearly 12% premarket on Wednesday after the U. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
Dec 24 (Reuters) - Sanofi will buy U. vaccines company Dynavax Technologies for around $2.
HYDERABAD, India, Dec 24 () - Global pharma giants Eli Lilly and Novo Nordisk are scrambling to cement their lead in India's booming obesity drug market before cheaper generic versions hit shelves in March next year. Novo's strategy emphasizes price cuts and accelerated launches, while Lilly's products benefitted from hitting the market early.
Food and Drug Administration's approval of an oral version of Novo Nordisk's weight-loss drug Wegovy could potentially expand access to millions of patients and give the Danish company a much-needed fillip in the red-hot market. The first GLP-1 pill specifically for obesity, also branded as Wegovy, is a 25-mg oral formulation of semaglutide, the active ingredient in the blockbuster injectable version.
Alex Yang details founding an AI startup with other high schoolers worldwide to improve Alzheimer's diagnostics.
Rick Steves is the guy to go to for budget traveling tips, and if you've set your eyes on Spain, this is the time he believes is best to visit.
Food and Drug Administration said on Friday it has authorized the marketing of six Altria-owned on. PLUS nicotine pouch products, through a pilot program aimed to fast-track reviews of such products.
March ICE NY cocoa (CCH26 ) on Friday closed down -89 (-1.50%), and March ICE London cocoa #7 (CAH26 ) closed down -43 (-0.99%). Cocoa prices extended this week's losses on Friday, with NY cocoa falling to a 1.5-week low. Favorable weather in West Africa is expected to boost yields...
Dec 19 () - BioMarin Pharmaceutical said on Friday it would acquire Amicus Therapeutics for about $4.8 billion, expanding its presence in rare metabolic diseases.